Training activity: 6

Details

Perform and interpret results and suggest follow-up testing and clinical management of the patient for feto-maternal haemorrhage (FMH) monitoring

Type

Developmental training activity (DTA)

Evidence requirements

Evidence the activity has been undertaken by the trainee​.

Reflection on the activity at one or more time points after the event including learning from the activity and/or areas of the trainees practice for development.

An action plan to implement learning and/or to address skills or knowledge gaps identified.

Considerations

• Use of and interpretation of Kleihauer acid elution test
• Use of and interpretation of results of FMH by flow cytometry
• Dosing calculation including differences in IV and IM delivery
• Relevant guidelines

Relevant learning outcomes

#	Outcome
# 1	Outcome Practice in accordance with antenatal serology standards and guidelines.
# 2	Outcome Perform acceptance testing of samples requiring antenatal investigation.
# 3	Outcome Perform and interpret clinical and laboratory investigations to identify cases of haemolytic disease of the fetus or newborn (HDFN).
# 4	Outcome Identify sequential testing algorithms appropriate to the samples under investigation for HDFN.
# 5	Outcome Predict current and future pregnancies at highest risk of HDFN.
# 6	Outcome Identify and advise healthcare professionals on appropriate actions to manage HDFN.
# 7	Outcome Develop management plans including selection of blood components for mother, fetus and neonates during pregnancy.
# 8	Outcome Identify actions required in cases of potentially sensitising events during pregnancy.